Phase I Randomized Trial of 0.3 mg Linaclotide ?Phase I Double-Blind, Placebo-Controlled Trial of 0.3 mg Linaclotide Delayed-Release (DR1) to Demonstrate Colorectal Bioactivity in Healthy Volunteers
- National Cancer Institute: $243,804.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.